Anthropic wants to develop its own drugs
Anthropic just shipped Claude Science. Now it's building drugs.
Why it matters
Anthropic is vertically integrating beyond AI infrastructure into pharmaceutical R&D, launching Claude Science as a specialized workbench for drug discovery. This signals a major shift: AI labs are no longer just selling models—they're using them to enter adjacent high-value industries.
The key facts
6 to knowAnthropic launches Claude Science, an AI workbench for scientists integrating fragmented tools and datasets
Platform generates figures and visuals for scientific research
Anthropic announced plans to develop its own drugs—moving beyond tools into pharma applications
Anthropic already has biotech and pharma customers using Claude
Event: 'The Briefing: AI for Science' where announcement was made
Framed around accelerating scientific discovery and healthcare intervention development
Go to the source
The Verge AItheverge.com
Publisher excerpt: At the event "The Briefing: AI for Science" earlier this week, Anthropic announced Claude Science, a new "AI workbench for scientists" that pulls fragmented tools and datasets into one environment, and generates figures and visuals. Anthropic, already dominating the industry with its popular coding…